Datasets:
ESGBERT
/
base_data

Dataset card Data Studio Files
xet
 Community
sentence
stringlengths
1
23.5k
⌀
AmerisourceBergen exists within a highly complex and dynamic healthcare environment.
the healthcare system overall, continues to be undeniable.
Our ability to drive efficiency and provide services within the supply chain is essential to patient care—ensuring that patients have access to vital pharmaceuticals when and where they need them.
As changes to various parts of the current healthcare model are considered, we are actively engaged with policy leaders, pharmaceutical manufacturers, healthcare providers and other stakeholders to ensure that changes do not negatively affect patient access to the best care possible and that our role in the supply chai...
To improve the sustainability of our operations, we have implemented practices that reduce energy use and waste as well as packaging innovations.
We’ve invested in two solar energy projects and sustainable building infrastructure, including new LEED certified office spaces.
organization, the AmerisourceBergen Foundation, we have been supporting health-related causes that enrich the global community.
Among the critical impacts that the Foundation has had, none is more important than the work being done to address the devastating effects of the opioid epidemic.
Through the work of our Foundation, we aim to mitigate the effects of the crisis and positively impact communities across the U.S. and the world.
The driving force behind everything we do is our Purpose—we are united in our responsibility to create healthier futures.
Our team of of strong corporate citizenship as a cornerstone to improving overall health.
While no single solution alone will ensure a healthier future, our efforts aim to boost our impact and reach.
To engage our workforce, we create an inclusive culture that prizes diversity.
Our core value, showing respect in the workplace, is supported by a heightened focus internally around our #connectwithrespect campaign, developed to foster an environment where everyone is heard, accepted and welcomed.
few years ago, we began to embed these core principles into our daily work.
It’s a crisis that hits at the heart of our industry and we continue to support measures for the safe disposal of opioids and resources for abuse prevention.
We’re also deeply committed to collaboration and partnership to increase access to care.
At a time when a lot of the world is not always working together, we are very intentional about collaborating with organizations, customers and stakeholders to amplify our impact and reach.
In Health, Family Reach and Southeastern Guide Dogs.
At the same time, we’ve deepened our relationships with our customers, associates and other members of the supply chain.
These partnerships are critical to achieving our corporate citizenship goals.
We have made tremendous progress, but we know more work is yet to be done.
In the coming year, we plan to integrate corporate citizenship even more deeply into our business, expand our diversity and inclusion efforts, scale our environmental sustainability efforts across the supply chain and convene our grantees and strategic partners to advance the work of the Foundation.
I want to thank all of our stakeholders for supporting us in these efforts.
the largest global pharmaceutical sourcing and distribution services companies, AmerisourceBergen’s focus is on patients.
Powered by the more than worldwide, we touch nearly every aspect of the pharmaceutical supply chain, offering expertise ranging from drug distribution and niche premium logistics to reimbursement capabilities and pharmaceutical consulting for both human and animal health.
than $ responsibility doesn’t end with the work we do.
AmerisourceBergen impacts the core of healthcare delivery with a focus on pharmaceutical care.
As a company, we are proud to be ranked # Fortune 500.
We shape healthcare delivery through knowledge, reach and partnership.
AmerisourceBergen has developed a corporate citizenship strategy that focuses on three priorities that align with our services and beliefs at the intersection of creating healthier futures.
considerations into every decision we make as a business and fulfill our commitment to acting as a good corporate citizen.
We are dedicated to engaging our associates and fostering an inclusive work environment.
We are committed to sustainable and responsible operations across the supply chain.
We are striving to help enable healthy and resilient communities nearby where we live and work.
in developing and executing corporate citizenship strategy and activities at AmerisourceBergen.
review of industry standards and best practices to identify our organization’s most material topics.
We know that it is our duty and responsibility to commit resources and expertise to advance prescription drug safety in the U.S.
Our ongoing commitment to fundamental human rights allows us to foster a diverse and inclusive work environment where associates of all backgrounds are treated with fairness, dignity and respect.
of overall healthcare, and this includes operating efficiently and reducing our carbon footprint wherever possible.
works to increase access to quality healthcare for both humans and animals and provide resources to ensure prescription drug safety.
commitment to patient care while delivering long-term shareholder value originates from a foundation of ethics, integrity and transparency, with patient safety at the core.
This serves as our cornerstone and guides how we act in service to our partners, patients and each other.
This enables us to clearly understand the healthcare environment and regulatory framework within which we work.
other and with our partners when creating solutions for patients.
We have a culture of compliance and transparency: associates can come forward without the fear of retaliation.
AmerisourceBergen Corporate Citizenship Overview Global Regulations Ethical behavior is imperative in our industry.
It is key to ensure patient safety – from proper labeling, to HIPPA protection, to ensuring we have strong processes in place.
Our Code of Ethics and Business Conduct applies throughout the enterprise, regardless of country.
In cross-border and overseas environments, AmerisourceBergen partners with authorities on a country-by-country basis to comply with evolving standards and in response to market dynamics while educating stakeholders on the important role we play in the healthcare supply chain.
and critical oversight of our governance, strategic initiatives, talent management and risk management processes.
Our Board ensures that our management team runs our business in a manner that protects and advances the long term interests of our shareholders.
with the oversight of our independent directors, including our Lead Independent Director, Dr. Jane E. Henney.
To enhance its oversight function, our Board is composed of directors who are not employed by AmerisourceBergen, with the exception of Steve Collis.
We are committed to a culture of integrity and transparency, to ultimately protect the patients we serve.
I encourage associates to contact me personally if there are any concerns they would like to raise.
We are determined to create a culture where associates can speak openly without fear of retaliation, so we can solve any challenges that arise.
these drugs would lead to patient access issues for those with legitimate medical needs.
Agency (DEA) approvals and clinical decisions made by healthcare providers to meet the needs of their patients.
While prescription opioid medications represent less than two percent of AmerisourceBergen’s annual revenue, we are determined to commit resources and expertise to help fight opioid misuse and abuse in the United States.
— a separate not-for-profit charitable organization — have committed to providing U.S. communities resources to help prevent the misuse and abuse of opioids.
We take no action to promote prescribing or otherwise increasing the demand for opioids and we do not offer our sales representatives compensation or incentives of any kind that target opioid orders.
Each center is equipped with state-of-the-art technology to keep our products secure and our associates safe.
distribution, maintaining operational integrity, advocating for the highest regulatory standards and community outreach.
Data indicates that the efforts of multiple stakeholders are making an impact.
However, as opioid abuse persists, we remain steadfastly committed to our efforts to help thwart the opioid epidemic.
Foundation are committed to making a difference in our communities and providing communities across the country resources to combat the epidemic of opioid misuse.
why we ensure that at every step of the supply chain and even beyond the supply chain, we are supplying resources, offering continuing education and granting funding to those who need it.
we are committed to being part of the solution.
AmerisourceBergen’s role in distribution is widespread – opioids constitute less than two percent of sales.
commitment at the community level to support those impacted by the opioid abuse crisis.
The Foundation focused on supporting programs and organizations that provide access to safe disposal of controlled substances, prevention education and innovative solutions to mitigating the crisis.
organizations that serve to protect the safe distribution of controlled substances.
This organization is on the forefront of ensuring that the distribution of opioids in the U.S. remains as safe and secure as possible.
We believe there is more work to be done to ensure safe patient access to controlled substances.
We have previously been vocal on the need for drug distributors to have full access to real-time ARCOS data (de-identified), as well as established opioid ordering protocols, mandatory digital ordering and the creation of a new DEA registrant classification and registrant fees, to fund the enhanced data capabilities.
Looking to we plan to continue our efforts to educate policymakers and other stakeholders on how the supply chain can best interact and support one another to ensure patient access and safety.
Our diversion control program is formulated to keep opioids out of the wrong hands, and traces its roots to the predecessor companies developed programs to identify and report suspicious orders.
Throughout the years, AmerisourceBergen has worked to improve its programs based upon new information and new technology.
Today, our diversion control program takes full advantage of the latest advanced data analysis tools to prevent opioid diversion, including mathematical algorithm and data analytics, peer group comparisons, interquartile range analysis and real-time dashboards with comprehensive ordering and customer information.
Our dedicated diversion control team of internal and external experts consists of former law enforcement professionals, diversion investigators and pharmacists or pharmacy technicians.
Collectively, they have more than experience in the industry.
In comprised of a cross-functional team of senior executives who meet regularly with the Vice President of Diversion Control to discuss, review and continuously improve our diversion control program.
At least annually, the diversion control team reevaluates all facets of the program.
The Foundation is committed to providing communities across the country resources to combat the epidemic of opioid abuse and misuse.
In December launched the Safe Disposal Support Program.
Through this initiative, the Foundation has distributed nearly deactivation kits to communities across 44 states to help encourage safe disposal.
drug deactivation resources, which were distributed at the fire and police departments, in addition to schools.
Resource Grant Program, which provides funding for new and constructive solutions to the opioid epidemic.
Since its inception in April from numerous non-profit and grant-funded organizations seeking support to broaden current efforts toward curbing opioid abuse.
Funding from the program has been, and will continue to be, allocated to organizations committed to pioneering new ideas, addressing the safe disposal of opioids and education around prevention.
To date, the Foundation has received more than of intent from not-for-profit organizations seeking support for opioid-related initiatives and the program has provided more than $3.4M in grants and in-kind donations.
External Advisory Committee to assist with requests and support the grant-making decision process.
span public health, community-based grant-making and community coalition building.
Along with the Foundation’s strategic partnerships with a variety of community-based organizations, detailed on the next page, we have expanded on our commitment to creating action oriented solutions.
The grant also enabled Eluna to expand its Camp Mariposa offerings to underserved youth and bolster the camp’s opioid addiction prevention resources and support services.
Plans are in place to expand this program into other geographies as part of a new three-year grant with Eluna.
The program will address the issue via patient education and engagement, as well as provider improvement strategies.
Pennsylvania National Surgical Quality Improvement Program, a voluntary association of across the state, and will leverage existing collaboration among the surgical departments at the medical centers.
Through this partnership, they will also recruit additional hospital-based surgical teams statewide to join the program and will be forming a Patient and Family Advisory Council.